GG 4
Pill imprint GG 4 has been identified as Atropine sulfate and diphenoxylate hydrochloride 0.025 mg / 2.5 mg.
Atropine/diphenoxylate is used in the treatment of diarrhea and belongs to the drug class antidiarrheals. Risk cannot be ruled out during pregnancy.
Atropine/diphenoxylate 0.025 mg / 2.5 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 4.
See also related documents.
Atropine sulfate and diphenoxylate hydrochloride Images
- Imprint:
-
GG 4
- Strength:
- 0.025 mg / 2.5 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
lactose monohydrate
pregelatinized starch
magnesium stearate
- Drug Class:
- Antidiarrheals
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-1262
| NDC Code | Manufacturer / Repackager |
|---|---|
| 57866-3763 | Direct Dispensing Inc (repackager) |
| 68115-0118 | Dispensexpress Inc (repackager) |
| 67544-0367 | Prepak Systems Inc (repackager) |
Note: Inactive ingredients may vary.
More Atropine Sulfate and Diphenoxylate Hydrochloride resources
- Atropine Sulfate and Diphenoxylate Hydrochloride Side Effects
- Atropine Sulfate and Diphenoxylate Hydrochloride Use in Pregnancy & Breastfeeding
- Atropine Sulfate and Diphenoxylate Hydrochloride Drug Interactions
- Support Group Q & A
- 23 Reviews for Atropine Sulfate and Diphenoxylate Hydrochloride - Add your own review/rating
- Atropine/Diphenoxylate (Wolters Kluwer)
- Atropine/Diphenoxylate Solution (Wolters Kluwer)
- atropine and diphenoxylate (Cerner Multum)
- diphenoxylate and atropine (Micromedex) - Includes Dosage Information
- Diphenoxylate Hydrochloride (AHFS DI)
- Diphenoxylate and Atropine (FDA)
- Diphenoxylate and Atropine Oral Solution (FDA)
- Diphenoxylate Hydrochloride/Atropine Sulfate (Wolters Kluwer)


